Lifespan brain activity, β-amyloid, and Alzheimer's disease

Trends in Cognitive Sciences

Volumn 15, Issue 11, 2011, Pages 520-526

  Jagust, William J ^a,b   Mormino, Elizabeth C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; ANIMAL STUDIES; BRAIN ACTIVITY; BRAIN REGIONS; COGNITIVE DECLINE; COGNITIVE NEUROSCIENCES; GENETIC PREDISPOSITION; HUMAN IMAGING; IN-VITRO; LIFE SPAN; MULTI-MODAL; POTENTIAL MECHANISM;

GLYCOPROTEINS; NEURODEGENERATIVE DISEASES;

BRAIN;

AMYLOID BETA PROTEIN; APOENZYME;

AGING; ALZHEIMER DISEASE; BRAIN DEGENERATION; COGNITIVE RESERVE; DENERVATION; ELECTROENCEPHALOGRAM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; IN VITRO STUDY; LIFESPAN; NERVE CELL PLASTICITY; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; BRAIN MAPPING; COGNITION DISORDERS; HUMANS; MODELS, BIOLOGICAL; NEURONS;

EID: 82455175189     PISSN: 13646613     EISSN: 1879307X     Source Type: Journal    
DOI: 10.1016/j.tics.2011.09.004     Document Type: Review

References (73)

1. Nitsch R.M., et al. Release of amyloid-beta protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:5191-5193.
2. Kamenetz F., et al. APP processing and synaptic function. Neuron 2003, 37:925-937.
3. Cirrito J.R., et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 2005, 48:913-922.
4. Bero A.W., et al. Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nat. Neurosci. 2011, 10.1038/nn.2801.
5. Kang J.E., et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009, 326:1005-1007.
6. Gilestro G.F., et al. Widespread changes in synaptic markers as a function of sleep and wakefulness in Drosophila. Science 2009, 324:109-112.
7. Brody D.L., et al. Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 2008, 321:1221-1224.
8. Ikonomovic M.D., et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 2008, 131:1630-1645.
9. Klunk W.E., et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004, 55:306-319.
10. Raichle M.E., et al. A default mode of brain function. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:676-682.
11. Greicius M.D., et al. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4637-4642.
12. Hedden T., et al. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J. Neurosci. 2009, 29:12686-12694.
13. Sperling R.A., et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 2009, 63:178-188.
14. Mormino E.C., et al. Relationships between beta-amyloid and functional connectivity in different components of the default mode network in aging. Cereb. Cortex 2011, 10.1093/cercor/bhr025.
15. Buckner R.L., et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 2005, 25:7709-7717.
16. Buckner R.L., et al. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J. Neurosci. 2009, 29:1860-1873.
17. Smith S.M., et al. Correspondence of the brain's functional architecture during activation and rest. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13040-13045.
18. Vaishnavi S.N., et al. Regional aerobic glycolysis in the human brain. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:17757-17762.
19. Vlassenko A.G., et al. Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:17763-17767.
20. Corder E.H., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
21. Ji Y., et al. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience 2003, 122:305-315.
22. Levi O., et al. ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol. Dis. 2003, 13:273-282.
23. Reiman E.M., et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 1996, 334:752-758.
24. Persson J., et al. Altered deactivation in individuals with genetic risk for Alzheimer's disease. Neuropsychologia 2008, 46:1679-1687.
25. Sheline Y.I., et al. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Abeta42. J. Neurosci. 2010, 30:17035-17040.
26. Verghese P.B., et al. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 2011, 10:241-252.
27. Kok E., et al. Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann. Neurol. 2009, 65:650-657.
28. Morishima-Kawashima M., et al. Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain. Am. J. Pathol. 2000, 157:2093-2099.
29. Valla J., et al. Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE epsilon4 allele, the major late-onset Alzheimer's susceptibility gene. J. Alzheimers Dis. 2010, 22:307-313.
30. Morris J.C., et al. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann. Neurol. 2010, 67:122-131.
31. Reiman E.M., et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:284-289.
32. Shaw P., et al. Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol. 2007, 6:494-500.
33. Alexopoulos P., et al. Hippocampal volume differences between healthy young apolipoprotein E epsilon2 and epsilon4 carriers. J. Alzheimers Dis. 2011, 10.3233/JAD-2011-110356.
34. Richter-Schmidinger T., et al. Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults. J. Neural Transm. 2010, 118:249-257.
35. Trachtenberg A.J., et al. The effects of APOE-epsilon4 on the BOLD response. Neurobiol. Aging 2010, 10.1016/j.neurobiolaging.2010.03.009.
36. Dennis N.A., et al. Temporal lobe functional activity and connectivity in young adult APOE varepsilon4 carriers. Alzheimers Dement. 2010, 6:303-311.
37. Filippini N., et al. Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage 2011, 54:602-610.
38. Filippini N., et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7209-7214.
39. Mondadori C.R., et al. Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb. Cortex 2007, 17:1934-1947.
40. Park D.C., Reuter-Lorenz P. The adaptive brain: aging and neurocognitive scaffolding. Annu. Rev. Psychol. 2009, 60:173-196.
41. Cabeza R., et al. Aging gracefully: compensatory brain activity in high-performing older adults. Neuroimage 2002, 17:1394-1402.
42. Nyberg L., et al. Longitudinal evidence for diminished frontal cortex function in aging. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:22682-22686.
43. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 1997, 18:351-357.
44. Mormino E.C., et al. Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage 2011, 10.1016/j.neuroimage.2011.07.098.
45. Masliah E., et al. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 1993, 43:192-197.
46. Vannini P., et al. Age and amyloid-related alterations in default network habituation to stimulus repetition. Neurobiol. Aging 2011, 10.1016/j.neurobiolaging.2011.01.003.
47. Mormino E., et al. Aβ deposition in aging is associated with increases in brain activation during successful memory encoding. Cereb. Cortex 2011, 10.1093/cercor/bhr255.
48. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
49. Herrup K. Reimagining Alzheimer's disease-an age-based hypothesis. J. Neurosci. 2010, 30:16755-16762.
50. Mesulam M.M. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 1999, 24:521-529.
51. Mucke L. Neuroscience: Alzheimer's disease. Nature 2009, 461:895-897.
52. Golde T.E., et al. Anti-abeta therapeutics in Alzheimer's disease: the need for a paradigm shift. Neuron 2011, 69:203-213.
53. Lacor P.N., et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J. Neurosci. 2007, 27:796-807.
54. Jack C.R., et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 9:119-128.
55. Hyman B.T. Amyloid-dependent and amyloid-independent stages of Alzheimer disease. Arch. Neurol. 2011, 10.1001/archneurol.2011.70.
56. Thal D.R., et al. Phases of Aβ deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58:1791-1800.
57. Sperling R.A., et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement. 2011, 10.1016/j.jalz.2011.03.003.
58. Dickerson B.C., et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann. Neurol. 2004, 56:27-35.
59. Schwindt G.C., Black S.E. Functional imaging studies of episodic memory in Alzheimer's disease: a quantitative meta-analysis. Neuroimage 2009, 45:181-190.
60. O'Brien J.L., et al. Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology 2010, 74:1969-1976.
61. Mondadori C.R., et al. Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Brain 2006, 129:2908-2922.
62. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J. Int. Neuropsychol. Soc. 2002, 8:448-460.
63. Chetelat G., et al. Larger temporal volume in elderly with high versus low beta-amyloid deposition. Brain 2010, 133:3349-3358.
64. Wilson R.S., et al. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA 2002, 287:742-748.
65. Fratiglioni L., et al. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 2004, 3:343-353.
66. Middleton L.E., Yaffe K. Targets for the prevention of dementia. J. Alzheimers Dis. 2010, 20:915-924.
67. Egan M.F., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:6917-6922.
68. Raizada R.D., et al. Socioeconomic status predicts hemispheric specialisation of the left inferior frontal gyrus in young children. Neuroimage 2008, 40:1392-1401.
69. Voss M.W., et al. Plasticity of brain networks in a randomized intervention trial of exercise training in older adults. Front. Aging Neurosci. 2010, 10.3389/fnagi.2010.00032.
70. Liang K.Y., et al. Exercise and Alzheimer's disease biomarkers in cognitively normal older adults. Ann. Neurol. 2010, 68:311-318.
71. Snowdon D.A., et al. Linguistic ability in early life and cognitive function and Azheimer's disease in late life: findings from the Nun study. JAMA 1996, 275:528-532.
72. Lazarov O., et al. Evironmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 2005, 120:701-713.
73. Mesulam M. Principles of behavioral and cognitive neurology 2000, Oxford University Press.